484002-06-4

Basic information

• Product Name: diosgenin-3-yl 2,3-di-O-acetyl-6-O-(2,3,4-tri-O-benzoyl-L-arabpyranosyl)-D-glucopyranoside
• Synonyms: diosgenin-3-yl 2,3-di-O-acetyl-6-O-(2,3,4-tri-O-benzoyl-L-arabpyranosyl)-D-glucopyranoside
• CAS NO: 484002-06-4
• Molecular Weight: 1105.29
• Mol File: 484002-06-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: diosgenin-3-yl 2,3-di-O-acetyl-6-O-(2,3,4-tri-O-benzoyl-L-arabpyranosyl)-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: diosgenin-3-yl 2,3-di-O-acetyl-6-O-(2,3,4-tri-O-benzoyl-L-arabpyranosyl)-D-glucopyranoside(484002-06-4)
• EPA Substance Registry System: diosgenin-3-yl 2,3-di-O-acetyl-6-O-(2,3,4-tri-O-benzoyl-L-arabpyranosyl)-D-glucopyranoside(484002-06-4)

Safety Data

• Hazardous Substances Data: 484002-06-4(Hazardous Substances Data)

Upstream product

• 512-04-9 diosgenin 
• 339276-12-9 2,3,4,6-tetra-O-benzoyl-D-glucopyranosyl 1-(N-phenyl)-2,2,2-trifluoroacetimidate 
• 211797-89-6 diosgenyl 4,6-O-benzylidene-β-D-glucopyranoside 
• 120969-06-4 diosgenyl 2,3,4,6-O-tetra-benzoyl-β-D-glucuronopyranoside 
• 14144-06-0 trillin 
• 484002-05-3 C₄₄H₆₀O₁₀ 

Relevant articles and documents

Glycosyl trifluoroacetimidates. 2. Synthesis of dioscin and Xiebai saponin I

Two trisaccharide steroidal saponins, dioscin (1) and Xiebai saponin I (2) with various bioactivities, were efficiently synthesized using the newly developed glycosyl N-phenyl trifluoroacetimidates (10-13) as glycosylation donors. Thus, dioscin was synthesized in five steps and a 33% overall yield from diosgenin and glycosyl trifluoroacetimidates (10 and 11). Xiebai saponin I was synthesized in eight steps and a 32% overall yield from laxogenin and glycosyl trifluoroacetimidates (10, 12, and 13), whereupon, the rare steroid laxogenin was prepared from diosgenin in four steps and an overall 69% yield. All the glycosylation reactions involved in the present syntheses demonstrated that glycosyl trifluoroacetimidates were successful donors comparable to the corresponding glycosyl trichloroacetimidates.